BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7525495)

  • 1. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.
    Castellani P; Viale G; Dorcaratto A; Nicolo G; Kaczmarek J; Querze G; Zardi L
    Int J Cancer; 1994 Dec; 59(5):612-8. PubMed ID: 7525495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiogenesis marker ED-B+ fibronectin isoform in intracranial meningiomas.
    Castellani P; Dorcaratto A; Pau A; Nicola M; Siri A; Gasparetto B; Zardi L; Viale G
    Acta Neurochir (Wien); 2000; 142(3):277-82. PubMed ID: 10819258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8.
    Ventura E; Sassi F; Parodi A; Balza E; Borsi L; Castellani P; Carnemolla B; Zardi L
    PLoS One; 2010 Feb; 5(2):e9145. PubMed ID: 20161770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.
    Carnemolla B; Balza E; Siri A; Zardi L; Nicotra MR; Bigotti A; Natali PG
    J Cell Biol; 1989 Mar; 108(3):1139-48. PubMed ID: 2646306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
    Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
    APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues.
    Kaczmarek J; Castellani P; Nicolo G; Spina B; Allemanni G; Zardi L
    Int J Cancer; 1994 Oct; 59(1):11-6. PubMed ID: 7927891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues.
    Borsi L; Balza E; Allemanni G; Zardi L
    Exp Cell Res; 1992 Mar; 199(1):98-105. PubMed ID: 1310473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin.
    Castellani P; Borsi L; Carnemolla B; Birò A; Dorcaratto A; Viale GL; Neri D; Zardi L
    Am J Pathol; 2002 Nov; 161(5):1695-700. PubMed ID: 12414516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8.
    Ventura E; Cordazzo C; Quarto R; Zardi L; Rosano C
    PLoS One; 2016; 11(2):e0148103. PubMed ID: 26867013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of fibronectin isoforms in human renal disease.
    Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
    J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain.
    Carnemolla B; Neri D; Castellani P; Leprini A; Neri G; Pini A; Winter G; Zardi L
    Int J Cancer; 1996 Nov; 68(3):397-405. PubMed ID: 8903484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ED-B fibronectin in non-small cell lung carcinoma.
    Khan ZA; Caurtero J; Barbin YP; Chan BM; Uniyal S; Chakrabarti S
    Exp Lung Res; 2005 Sep; 31(7):701-11. PubMed ID: 16203624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedure for the purification of the fibronectin proteolytic fragments containing the ED-B oncofetal domain.
    Borsi L; Balza E; Leprini A; Ponassi M; Zardi L
    Anal Biochem; 1991 Feb; 192(2):372-9. PubMed ID: 2035837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis.
    Kriegsmann J; Berndt A; Hansen T; Borsi L; Zardi L; Bräuer R; Petrow PK; Otto M; Kirkpatrick CJ; Gay S; Kosmehl H
    Rheumatol Int; 2004 Jan; 24(1):25-33. PubMed ID: 12712258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin isoforms are differentially expressed in normal and adenomatous human anterior pituitaries.
    Farnoud MR; Farhadian F; Samuel JL; Derome P; Peillon F; Li JY
    Int J Cancer; 1995 Mar; 61(1):27-34. PubMed ID: 7705930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence.
    Carnemolla B; Leprini A; Allemanni G; Saginati M; Zardi L
    J Biol Chem; 1992 Dec; 267(34):24689-92. PubMed ID: 1280266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis-associated extra type III domain B.
    Balza E; Sassi F; Ventura E; Parodi A; Fossati S; Blalock W; Carnemolla B; Castellani P; Zardi L; Borsi L
    Int J Cancer; 2009 Aug; 125(4):751-8. PubMed ID: 19479996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors.
    Oyama F; Hirohashi S; Sakamoto M; Titani K; Sekiguchi K
    Cancer Res; 1993 May; 53(9):2005-11. PubMed ID: 8481903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren's disease.
    Halliday NL; Rayan GM; Zardi L; Tomasek JJ
    J Hand Surg Am; 1994 May; 19(3):428-34. PubMed ID: 8056970
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.